Insider Transactions in Q4 2025 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Indirect |
21,070
-10.1%
|
-
|
|
Dec 22
2025
|
Saira Ramasastry |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$400,000
$80.0 P/Share
|
|
Dec 22
2025
|
Saira Ramasastry |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$115,000
$23.51 P/Share
|
|
Dec 19
2025
|
Michael G Grey |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$3,900,000
$78.0 P/Share
|
|
Dec 19
2025
|
Michael G Grey |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$100,000
$2.94 P/Share
|
|
Dec 18
2025
|
Saira Ramasastry |
SELL
Open market or private sale
|
Direct |
2,000
-75.0%
|
$138,000
$69.73 P/Share
|
|
Dec 18
2025
|
Saira Ramasastry |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$46,000
$23.51 P/Share
|
|
Dec 01
2025
|
Michael G Grey |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$3,700,000
$74.0 P/Share
|
|
Dec 01
2025
|
Michael G Grey |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$100,000
$2.94 P/Share
|
|
Nov 21
2025
|
Michael G Grey |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$3,500,000
$70.0 P/Share
|
|
Nov 21
2025
|
Michael G Grey |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$100,000
$2.94 P/Share
|
|
Nov 18
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
19,133
+10.8%
|
$363,527
$19.24 P/Share
|